Company · CIK 1633070
Axcella Health Inc.
| CIK | 1633070 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2019-06-20 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-238983 | 2020-06-05 | 2022-10-13 | 5 | |
| 333-238168 | 2020-05-11 | 2020-05-14 | 3 | |
| 333-230822 | 2019-04-12 | 2019-05-09 | 5 |
Filings
15| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2022-10-13 | 424B5Shelf takedown | 333-238983 | 0001104659-22-108287 |
| 2022-03-16 | 424B5Shelf takedown | 333-238983 | 0001104659-22-034224 |
| 2020-06-12 | EFFECTDeclared effective | 333-238983 | 9999999995-20-001420 |
| 2020-06-12 | 424B5Shelf takedown | 333-238983 | 0001104659-20-072939 |
| 2020-06-05 | S-3Shelf registered | 333-238983 | 0001104659-20-070391 |
| 2020-05-14 | 424B4Final prospectus | 333-238168 | 0001047469-20-003070 |
| 2020-05-13 | EFFECTDeclared effective | 333-238168 | 9999999995-20-001153 |
| 2020-05-11 | S-1Registration filed | 333-238168 | 0001047469-20-002985 |
| 2020-04-03 | DRSDraft made public | 377-03110 | 0000912057-20-000119 |
| 2019-05-09 | 424B4Final prospectus | 333-230822 | 0001047469-19-002985 |
| 2019-05-08 | EFFECTDeclared effective | 333-230822 | 9999999995-19-001045 |
| 2019-05-06 | S-1/AAmendment | 333-230822 | 0001047469-19-002887 |
| 2019-04-30 | S-1/AAmendment | 333-230822 | 0001047469-19-002716 |
| 2019-04-12 | S-1Registration filed | 333-230822 | 0001047469-19-002181 |
| 2019-01-28 | DRSDraft made public | 377-02476 | 0000912057-19-000028 |